http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2010000123-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
filingDate 2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2683ba6dfa557e7fe9288a7aabab9966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1ea686d053782a35bbcad1e4247b01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e88250f2a1d61665951726853be577c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_839898472b1c80da86b218bab71be12f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7641d5ced64b30121e754c7a6da0b1b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9f889911313f412a9d6b6a646b9bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bbaad5411a33de31a1c84f329b9e976
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58522cee7156beb4caf852c941af188b
publicationDate 2010-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2010000123-A
titleOfInvention ANTI-HEPCIDINE ANTIBODIES
abstract The present invention relates to monoclonal antibodies that selectively bind human hepcidin-25 and are characterized by having high affinity for human hepcidin-25 and strong neutralizing properties to mature human hepcidin. The antibodies of the invention are therapeutically useful for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and / or hematocrit in a human, and for the treatment and diagnosis of disorders promoted by Mature hepcidin, such as anemia, in a human subject.
priorityDate 2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185

Total number of triples: 29.